H7N9 Mix and Match With AS03 and MF59 in Healthy Adults

NCT01942265 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

980

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

DRUG: AS03
DRUG: MF59
BIOLOGICAL: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)